Pharmacology News

Each year, from Nov. 18 to Nov. 24, the CDC’s U.S. Antibiotic Awareness Week raises awareness about antimicrobial resistance and encourages the appropriate use of antibiotics and antifungals.

Researchers found evidence of artemisinin partial resistance in Ugandan children with complicated malaria, according to data presented at the Annual Meeting of the American Society of Tropical Medicine and Hygiene.

Researchers presented data at IDWeek showing that socioeconomic vulnerability and race can negatively impact vaccine uptake.

SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses and weekly injectables for efficacy and safety, a speaker reported.

The FDA has proposed an order for the removal of oral phenylephrine as an active ingredient from over-the-counter monograph drug products for relieving nasal congestion, according to an administration press release.

Pregabalin and topiramate significantly reduced the frequency and intensity of migraines in children and adolescents, especially when combined with vitamin supplements, according to a meta-analysis published in JAMA Network Open.

SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported.

SAN ANTONIO —An intestinal microsomal triglyceride transfer protein inhibitor reduced postprandial triglycerides and halted weight gain in patients treated with the antipsychotic olanzapine, according to results of a pilot study.

Products claiming to work like GLP-1s are popular and misleading, but primary care providers can help their patients avoid potentially dangerous supplements, according to experts.